4.7 Article

Composition of Coronary Thrombus in Acute Myocardial Infarction

期刊

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 57, 期 12, 页码 1359-1367

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2010.09.077

关键词

STEMI; thrombus

资金

  1. Federation Francaise de Cardiologie
  2. Institut de l'Atherothrombose
  3. NIH [HL30954, HL090774, T32 HL07439]
  4. Daiichi-Sankyo
  5. Eli Lilly
  6. Sanofi-Aventis
  7. INSERM
  8. Societe Francaise de Cardiologie
  9. Boston Scientific
  10. Bristol-Myers Squibb
  11. Centocor
  12. Cordis
  13. Fondation de France
  14. Guerbet Medical
  15. Medtronic
  16. Stago
  17. Roche
  18. Pfizer
  19. Astellas
  20. Servier
  21. Abbott
  22. CLS Behring
  23. AstraZeneca
  24. Abbott Vascular
  25. ITC Edison
  26. Daiichi
  27. Eisai
  28. Menarini
  29. Novartis
  30. Portola
  31. Schering-Plough
  32. Medicines Company
  33. Accumetrics
  34. GlaxoSmithKline
  35. Merck Sharpe Dohme

向作者/读者索取更多资源

Objectives We sought to analyze the composition of coronary thrombus in vivo in ST-segment elevation myocardial infarction (STEMI) patients. Background The dynamic process of intracoronary thrombus formation in STEMI patients is poorly understood. Methods Intracoronary thrombi (n = 45) were obtained by thromboaspiration in 288 consecutive STEMI patients presenting for primary percutaneous intervention, and analyzed using high-definition pictures taken with a scanning electron microscope. Plasma biomarkers (TnI, CRPus, IL-6, PAI-1, sCD40 ligand, and TNF-alpha) and plasma fibrin clot viscoelastic properties were measured simultaneously on peripheral blood. Results Thrombi were mainly composed of fibrin (55.9 +/- 18%) with platelets (16.8 +/- 18%), erythrocytes (11.5 +/- 9%), cholesterol crystals (5.2 +/- 8.4%), and leukocytes (1.3 +/- 2.0%). The median ischemic time was 175 min (inter-quartile range: 140 to 297). Ischemic time impacted thrombi composition, resulting in a positive correlation with intracoronary thrombus fibrin content, r = 0.38, p = 0.01, and a negative correlation with platelet content, r = -0.34, p = 0.02. Thus, fibrin content increased with ischemic time, ranging from 48.4 +/- 21% (<3 h) up to 66.9 +/- 9% (>6 h) (p = 0.02), whereas platelet content decreased from 24.9 +/- 23% (<3 h) to 9.1 +/- 6% (>6 h) (p = 0.07). Soluble CD40 ligand was positively correlated to platelet content in the thrombus (r = 0.40, p = 0.02) and negatively correlated with fibrin content (r = -0.36; p = 0.04). Multivariate analysis indicated that ischemic time was the only predictor of thrombus composition, with a 2-fold increase of fibrin content per ischemic hour (adjusted odds ratio: 2.00 [95% confidence interval: 1.03 to 3.7]; p = 0.01). Conclusions In acute STEMI, platelet and fibrin contents of the occlusive thrombus are highly dependent on ischemia time, which may have a direct impact on the efficacy of drugs or devices used for coronary reperfusion. (J Am Coll Cardiol 2011;57:1359-67) (C) 2011 by the American College of Cardiology Foundation

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据